|
|
Article: Hay fever jab offers high hopes for AT.
- Article from:
- The Mail on Sunday (London, England)
- Article date:
- May 13, 2007
CopyrightCOPYRIGHT 2007 Solo Syndication Limited. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Byline: JOANNE HART
ALLERGY Therapeutics is another company with a long history, tracing its origins back to before the Second World War. The group makes products designed to cure and prevent allergies.
Unlike many biotech companies, AT, which floated in 2004, has treatments in circulation so it already generates profits.
It is in the advanced stages of launching a radical hay fever treatment, designed for people who suffer for months at a time.
AT's Pollinex Quattro Ragweed injection could provide a remedy. At present, most injection courses must begin before the hay fever season and involve up to 50 treatments. Ragweed involves only ...